Champions Oncology to Participate in the Craig-Hallum Alpha Select Investor Conference

Tuesday, November 7, 2017 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

HACKENSACK, N.J., Nov. 7, 2017 /PRNewswire/ -- Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced

technology solutions and services to personalize the development and use of oncology drugs, will be participating in the 8th Annual Craig-Hallum Alpha Select Conference on November 16th. The conference is being held at the
Sheraton New York Times Square Hotel in New York City.

Management will host one-on-one meetings throughout the day. To schedule a meeting, please contact your Craig-Hallum representative, or Hayden IR.

About Champions Oncology, Inc.

Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The Company's TumorGraft technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments, or TumorGrafts, in a manner that preserves the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen.  The Company uses this technology in conjunction with related services to offer solutions for two customer groups:  Personalized Oncology Solutions, in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. TumorGrafts are procured through agreements with a number of institutions in the U.S. and overseas as well as through Champions' Personalized Oncology Solutions business. For more information, please visit www.championsoncology.com.

Contact: James CarbonaraHayden IR(646)-755-7412[email protected]

Brett Maas Hayden IR (646) 536-7331[email protected]

 

View original content:http://www.prnewswire.com/news-releases/champions-oncology-to-participate-in-the-craig-hallum-alpha-select-investor-conference-300550501.html

SOURCE Champions Oncology, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store